Recovery of ceftazidime-resistant Klebsiella pneumoniae from pediatric liver and intestinal transplant recipients

Pediatric Transplantation

Volumn 2, Issue 3, 1998, Pages 224-230

  Green, Michael ^a   Barbadora, Karen ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Ceftazidime resistant bacteria; Transplantation

Indexed keywords

CEFTAZIDIME;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; DRUG EFFECT; ENTEROBACTER INFECTION; FECES; HUMAN; INFANT; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PULSED FIELD GEL ELECTROPHORESIS; SMALL INTESTINE; TRANSPLANTATION;

ADOLESCENT; CEFTAZIDIME; CEPHALOSPORIN RESISTANCE; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, PULSED-FIELD; FECES; HUMANS; INFANT; INTESTINE, SMALL; KIDNEY TRANSPLANTATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POSTOPERATIVE COMPLICATIONS;

EID: 0032129783     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. GREEN M, REYES J, NOUR B, TZAKIS A, TODO S. Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. Transplant Proc 1994: 26: 1420-1421.
2. WAGENER WM, YU VL. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors and outcomes. Am J Infect Control 1992: 20: 239-247.
3. PHILIPPON A, LABIA R, JACOBY G. Extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1989: 33: 1131-1136.
4. GREEN M, BARBADORA K, DONABEDIAN S, ZERVOS MJ. Comparison of field inversion gel electrophoresis to contour-clamped homogenous electrophoresis as a typing method for Enterococcus faecium. J Clin Microbiol 1995: 33: 1554-1557.
5. TENOVER F, ARBEIT R, GOERING R, et al. Interpreting chromosomal DNA restriction patterns produced by pulsedfield electrophoresis: criteria for strain typing. J Clin Microbiol 1995: 33: 2233-2239.
6. BURMAN LG, HAEGGMAN S, KUISTILA M, TULLUS K, HUOVINEN P. Epidemiology of plasmid-mediated beta-lactamases in Enterobacteria in Swedish neonatal wards and relation to antimicrobial therapy. Antimicrob Agents Chemother 1992: 36: 989-992.
7. NAUMOVSKI L, QUINN JP, MIYASHIRO D. et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992: 36: 1991-1996.
8. BINGEN EH, DESJARDINS P, GUILLAUME A, et al. Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamse-producing Klebsiella pneumoniae isolates in a pediatric hospital. J Clin Microbiol 1993: 31: 179-184
9. GOUBY A, NEUWIRTH C, BOURG G, et al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994: 32: 301-305.
10. NOUVELLON M, PONS JL, SIROT D, COMBE ML, LEMELAND JF. Clonal outbreaks of extended-spectrum beta-lactamase-producing strains of Klebsiella pneumoniae demonstrated by antibiotic susceptibility testing, beta-lactamse typing, multilocus enzyme electrophoresis. J Clin Microbiol 1994: 32: 2625-2627.
11. RASMUSSEN BA, BRADFORD PA, QUINN JP, et al. Genetically diverse ceftazidime-resistant isolates from a singel center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother 1993: 37: 1989-1992.
12. URBAN C, MEYER K, MARIANO N, et al. Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 1994: 38: 392-395.
13. ARLET G, ROUVEAU M, CASIN I, et al. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French Hospitals. J Clin Microbiol 1994: 32: 2553-2558.
14. SCHIAPPA DA, HAYDEN MK, MATUSHEK MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996: 174: 529-536.
15. RICE LB, ECKSTEIN EC, DEVENTE J, SHLAES DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affair Medical Center. Clin Infect Dis 1996: 23: 118-124.
16. GAZOULI M, KAUFMANN ME, TZELEPI E, et al. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol 1997: 35: 508-510.
17. RICE LB, CARIAS LL, BONOMO RA, SHLAES DM. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy J Infect Dis 1996: 173: 151-158.
18. JACOBY GA, HAN P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996: 34: 908-911.
19. LINDEN PK, PASCULLE AW, MANEZ R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996: 22: 663-670.
20. Hospital Infection Control Practices Advisory Committee. Recommendations g1 for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995: 16: 105-113.
21. GREEN M. Vancomycin resistant enterococci: impact and management in pediatrics. Adv Pediatr Infect Dis 1997: 13: 257-277.